- Home
- BRBR vs ADMA Comparison
BRBR vs ADMA Comparison
Compare BRBR & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRBR
- ADMA
- Stock Information
- Founded
- BRBR 2019
- ADMA 2004
- Country
- BRBR United States
- ADMA United States
- Employees
- BRBR N/A
- ADMA N/A
- Industry
- BRBR Packaged Foods
- ADMA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BRBR Consumer Staples
- ADMA Health Care
- Exchange
- BRBR Nasdaq
- ADMA Nasdaq
- Market Cap
- BRBR 3.7B
- ADMA 4.1B
- IPO Year
- BRBR 2019
- ADMA N/A
- Fundamental
- Price
- BRBR $30.65
- ADMA $19.41
- Analyst Decision
- BRBR Buy
- ADMA Strong Buy
- Analyst Count
- BRBR 16
- ADMA 2
- Target Price
- BRBR $46.88
- ADMA $28.50
- AVG Volume (30 Days)
- BRBR 4.8M
- ADMA 4.0M
- Earning Date
- BRBR 11-18-2025
- ADMA 11-05-2025
- Dividend Yield
- BRBR N/A
- ADMA N/A
- EPS Growth
- BRBR N/A
- ADMA 205.35
- EPS
- BRBR 1.68
- ADMA 0.86
- Revenue
- BRBR $2,316,600,000.00
- ADMA $488,559,000.00
- Revenue This Year
- BRBR $11.02
- ADMA $21.08
- Revenue Next Year
- BRBR $8.94
- ADMA $25.98
- P/E Ratio
- BRBR $18.21
- ADMA $22.36
- Revenue Growth
- BRBR 16.05
- ADMA 27.63
- 52 Week Low
- BRBR $22.45
- ADMA $13.50
- 52 Week High
- BRBR $80.67
- ADMA $25.67
- Technical
- Relative Strength Index (RSI)
- BRBR 52.50
- ADMA 75.07
- Support Level
- BRBR $29.31
- ADMA $15.22
- Resistance Level
- BRBR $31.14
- ADMA $16.67
- Average True Range (ATR)
- BRBR 1.54
- ADMA 0.78
- MACD
- BRBR 0.60
- ADMA 0.44
- Stochastic Oscillator
- BRBR 94.45
- ADMA 98.69
About BRBR BellRing Brands Inc.
BellRing Brands Inc is a United States-based company engaged in providing nutrition-related products. Its brands, Premier Protein, Dymatize, and PowerBar provides various products including ready-to-drink protein shakes, powders and nutrition bars. The company's products are distributed through a diverse network of channels including club, food, drug and mass, eCommerce, convenience and specialty.
About ADMA ADMA Biologics Inc
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.